Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Mastocytosis, Systemic × Denosumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Prostatic Neoplasms 6 Neoplasms 6 Multiple Myeloma 4 Fractures, Bone 4 Osteoporosis 3 Bone Diseases, Metabolic 3 Spinal Cord Compression 2 Giant Cell Tumor of Bone 2 Bone Diseases 2 Parathyroid Neoplasms 1 Paraproteinemias 1 Neoplastic Processes 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Mastocytosis, Systemic 1 Lymphoma 1 Hyperparathyroidism, Primary 1 Hormone Refractory Prostate Cancer 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Cataract 1 Castrate-resistant Prostate Cancer 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Diseases 1 Bone Neoplasms 1 Bone Metastases From Solid Tumors 1 Bone Metastases 1

Interventions

masitinib 2 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03401060 2024-05-03

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡